Use of a novel anti-apoptotic agent (LXR017) reduces infarct size following ischemia-reperfusion in the canine myocardium by Silver, M.J., Chetculi, S.P., Mukherjee, D.B., Malyaky, J.L., Tomei, D.L., Umansky, S., Nicolini, F.A.

Get full text